Abbott, AstraZeneca seek cholesterol pill approval

(AP) -- Abbott Laboratories and AstraZeneca PLC on Thursday asked the Food and Drug Administration to approve a drug that combines their cholesterol pills TriLipix and Crestor.

If you want to include this story in your blog, copy and paste this formatted text:

<p><a href="http://www.physorg.com/news163335719.html">Abbott, AstraZeneca seek cholesterol pill approval</a></p> <p>(AP) -- Abbott Laboratories and AstraZeneca PLC on Thursday asked the Food and Drug Administration to approve a drug that combines their cholesterol pills TriLipix and Crestor.</p>